🔴 Femasys is trading 5.6% down in after-hours trading with no confirmed company-specific catalyst

Femasys is trading 5.6% lower at $1.54, with no confirmed company-specific announcement explaining the after-hours decline.

• The October 19 regular-session close was $1.63.
• On October 14, Femasys announced it had doubled actively enrolling FemBloc trial sites to twelve; that update does not establish a reason for the decline.
• Major U.S. indices were higher, which does not clearly explain the stock’s opposite-direction move.